LUCY · Innovative Eyewear Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $773.6K | - | $668.1K | $579.2K | $454.5K | - | $253.6K | $308.7K | $383.5K | - |
| Cost of Revenue | $598.1K | - | $423.3K | $591.9K | $234.0K | - | $194.3K | $253.5K | $376.5K | - |
| Gross Profit | $175.4K | - | $244.8K | ($12.7K) | $220.5K | - | $59.3K | $55.2K | $7.0K | - |
| R&D | $138.1K | - | $130.0K | $268.2K | $210.6K | - | $131.4K | $256.8K | $216.3K | - |
| SG&A | $1.59M | - | $1.28M | $1.31M | $1.09M | - | $1.12M | $1.30M | $1.11M | - |
| Total Operating Expenses | $2.55M | - | $2.17M | $2.16M | $2.12M | - | $1.82M | $2.03M | $2.02M | - |
| D&A | $11.6K | - | $14.9K | $17.2K | $21.2K | - | $24.0K | $38.3K | $21.7K | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Net Income | ($2.31M) | - | ($1.84M) | ($2.11M) | ($1.78M) | - | ($1.72M) | ($1.95M) | ($1.97M) | - |
| EPS - Basic | ($0.37) | - | ($0.38) | ($0.66) | ($0.72) | - | ($0.99) | ($1.87) | ($3.00) | - |
| EPS - Diluted | ($0.37) | - | ($0.38) | ($0.66) | ($0.72) | - | ($0.99) | ($1.87) | ($3.00) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.38M | $6.51M | $6.70M | $7.63M | $5.26M | $2.63M | $4.54M | $5.90M | $2.65M | $4.29M |
| Accounts Receivable | $71.5K | $142.2K | $83.4K | $58.0K | $89.7K | $107.9K | $80.9K | $61.6K | $52.8K | $93.2K |
| Inventory | $1.40M | $1.75M | $1.63M | $1.68M | $1.13M | $831.8K | $915.2K | $930.5K | $858.9K | $533.2K |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $8.75M | $9.44M | $10.60M | $11.33M | $7.33M | $9.24M | $10.99M | $7.29M | $4.11M | $5.62M |
| Total Assets | $9.48M | $10.14M | $11.18M | $11.94M | $7.94M | $9.84M | $11.60M | $7.86M | $4.81M | $6.22M |
| Current Liabilities | $1.09M | $1.05M | $884.7K | $606.1K | $447.2K | $737.7K | $653.0K | $494.6K | $883.5K | $624.5K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $1.11M | $1.07M | $925.0K | $658.5K | $447.2K | $743.2K | $665.9K | $515.1K | $911.4K | $659.9K |
| Stockholders' Equity | $8.37M | $9.07M | $10.25M | $11.28M | $7.49M | $9.10M | $10.93M | $7.34M | $3.90M | $5.56M |
| Retained Earnings | ($34.64M) | ($32.33M) | ($30.46M) | ($28.62M) | ($26.51M) | ($24.74M) | ($22.61M) | ($20.89M) | ($18.94M) | ($16.97M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($2.49M) | - | - | - | ($2.31M) | - | - | - | ($1.47M) | - |
| Investing Cash Flow | ($1.05M) | - | - | - | $4.94M | - | - | - | ($95.5K) | - |
| Financing Cash Flow | $1.40M | - | - | - | - | - | - | - | ($76.0K) | - |
| CapEx | - | - | - | - | $40.6K | - | - | - | $32.3K | - |
| Free Cash Flow | - | - | - | - | ($2.35M) | - | - | - | ($1.50M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 22.7% | - | 36.6% | -2.2% | 48.5% | - | 23.4% | 17.9% | 1.8% | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -298.5% | - | -274.8% | -363.6% | -391.4% | - | -678.5% | -631.2% | -514.1% | - |
| Free cash flow margin | - | - | - | - | -517.4% | - | - | - | -391.1% | - |
| FCF / Net income | - | - | - | - | 1.32 | - | - | - | 0.76 | - |
| R&D / Revenue | 17.9% | - | 19.5% | 46.3% | 46.3% | - | 51.8% | 83.2% | 56.4% | - |
| SG&A / Revenue | 205.5% | - | 191.2% | 226.3% | 240.1% | - | 442.4% | 419.6% | 289.2% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -24.4% | - | -16.4% | -17.6% | -22.4% | - | -14.8% | -24.8% | -41.0% | - |
| Return on equity | -27.6% | - | -17.9% | -18.7% | -23.7% | - | -15.7% | -26.5% | -50.5% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 8.02 | 9.03 | 11.98 | 18.70 | 16.39 | 12.52 | 16.83 | 14.73 | 4.65 | 8.99 |
| Quick ratio | 6.73 | 7.36 | 10.13 | 15.93 | 13.87 | 11.40 | 15.43 | 12.85 | 3.68 | 8.14 |
| Cash ratio | 4.01 | 6.23 | 7.57 | 12.59 | 11.76 | 3.56 | 6.96 | 11.92 | 3.00 | 6.87 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.13 | 1.12 | 1.09 | 1.06 | 1.06 | 1.08 | 1.06 | 1.07 | 1.23 | 1.12 |
| Liabilities / Assets | 0.12 | 0.11 | 0.08 | 0.06 | 0.06 | 0.08 | 0.06 | 0.07 | 0.19 | 0.11 |
| Efficiency | ||||||||||
| Asset turnover | 0.08 | - | 0.06 | 0.05 | 0.06 | - | 0.02 | 0.04 | 0.08 | - |
| Inventory turnover | 0.43 | - | 0.26 | 0.35 | 0.21 | - | 0.21 | 0.27 | 0.44 | - |
| Days sales outstanding | 34d | - | 46d | 37d | 72d | - | 116d | 73d | 50d | - |
| Days inventory outstanding | 857d | - | 1408d | 1034d | 1760d | - | 1720d | 1340d | 833d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 0.8x | - | 0.9x | 0.6x | 0.9x | - | 1.3x | 1.4x | 18.1x | - |
| P / S | 8.8x | - | 14.1x | 11.8x | 14.0x | - | 57.2x | 33.5x | 184.4x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 70.2% | - | 163.5% | 87.6% | 18.5% | - | 14.3% | 81.7% | 62.5% | - |
| Revenue CAGR (3y) | 48.5% | - | 63.8% | 65.8% | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -20.4% | - | 312.6% | - | 3072.7% | - | -26.1% | - | -32.5% | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | -29.8% | - | -6.7% | -8.1% | 9.8% | - | -10.9% | -51.3% | -37.8% | - |
| EPS growth (YoY) | 48.6% | - | 61.6% | 64.7% | 76.0% | - | -725.0% | -1146.7% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | -56.8% | - | - | - | -127.6% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 11.7% | -0.3% | -6.2% | 53.6% | 92.1% | 63.6% | 43.0% | -18.0% | -14.3% | 38.1% |
Peer comparison
Same SIC group: Ophthalmic Goods
Comparing Innovative Eyewear Inc against the 5 most active filers in the same SIC group.